Background: The etiology of the autoimmune thyroid diseases (AITDs), Graves’ disease (GD) is largely unknown. However, genetic susceptibility is believed to play a major role. The lymphoid tyrosine phosphatase (LYP), encoded by the protein tyrosine phosphatase-22 (PTPN22) gene, is a powerful inhibitor of T cell activation. Recently, a single-nucleotide polymorphism (SNP), encoding a functional arginine to tryptophan residue change at PTPN22 has been shown to be associated with GD and other autoimmune diseases. Aim: We aimed to analyze whether SNP of PTPN22 gene has any association with GD in Kumaon population. Method: We have used a polymerase chain reaction (PCR)-restriction fragment (XcmI) assay to examine genotypes polymorphism in 50 unrelated patients with AITD and 50 controls. Results: Among the patients with GD, the frequencies of PTPN22 CC, CT, and TT genotypes were 66%, 24%, and 6%, respectively, whereas in healthy controls the frequencies of CC, CT genotypes we CC, CT, and TT genotypes re 62%, 30% and 8% respectively. No significant association was found between PTPN22 C/T SNP and patients with GD. Conclusion: GD is not associated with PTPN22 C/T SNP in Kumaon population. Furthermore, C/T SNP in PTPN22 gene could be a part of variation in different ethnic populations across the globe.